[西班牙支气管源性癌的外科手术。一项描述性研究。西班牙呼吸与胸外科协会支气管源性癌合作组（GCCB-S）] - Suppr | 超能文献

[The surgery of bronchogenic carcinoma in Spain. A descriptive study. The Cooperative Group on Bronchogenic Carcinoma of SEPAR (GCCB-S). Sociedad Española de Neumología y Cirugía Torácica].

出版信息

Arch Bronconeumol. 1995 Jun-Jul;31(6):303-9.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[The surgery of bronchogenic carcinoma in Spain. A descriptive study. The Cooperative Group on Bronchogenic Carcinoma of SEPAR (GCCB-S). Sociedad Española de Neumología y Cirugía Torácica].[西班牙支气管源性癌的外科手术。一项描述性研究。西班牙呼吸与胸外科协会支气管源性癌合作组（GCCB-S）]

Arch Bronconeumol. 1995 Jun-Jul;31(6):303-9.

2

[The diagnosis and treatment of community-acquired pneumonia. SEPAR. Sociedad Española de Neumología y Cirugía Torácica].[社区获得性肺炎的诊断与治疗。SEPAR。西班牙胸科与心血管外科学会]

Arch Bronconeumol. 1997 May;33(5):240-6. doi: 10.1016/s0300-2896(15)30614-1.

3

The Spanish data base for the staging of lung cancer. Experience of the Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S).西班牙肺癌分期数据库。西班牙肺科与胸外科协会支气管源性癌协作组（GCCB-S）的经验。

Ann Ital Chir. 1999 Nov-Dec;70(6):907-8.

4

[Guidelines for the diagnosis and treatment of pneumothorax. The Working Group of SEPAR. Sociedad Española de Neumología y Cirurgía Torácica].[气胸诊断与治疗指南。西班牙胸科协会（SEPAR）工作组。西班牙胸科与胸廓外科学会]

Arch Bronconeumol. 1995 Aug-Sep;31(7):339-45.

5

[Guideline for the use of inhaled drugs. The Working Group of SEPAR: the Nursing Area of the Sociedad Española de Neumología y Cirugía Torácica].[吸入药物使用指南。西班牙胸科协会护理领域SEPAR工作组]

Arch Bronconeumol. 2000 Jan;36(1):34-43. doi: 10.1016/s0300-2896(15)30231-3.

6

[Guidelines for the treatment of smoking. The Working Group for the Treatment of Smoking of the Smoking Area. SEPAR (Sociedad Española de Neumología y Cirugía Torácica)].[吸烟治疗指南。吸烟区治疗工作组。西班牙胸科与心血管外科学会（SEPAR）]

Arch Bronconeumol. 1999 Nov;35(10):499-506. doi: 10.1016/s0300-2896(15)30025-9.

7

[Bronchogenic carcinoma invading the thoracic wall. The results of surgical treatment].[支气管源性癌侵犯胸壁。外科治疗结果]

Minerva Med. 1989 Jul;80(7):679-83.

8

[A nonpharmacological therapeutic strategy: inferior vena cava filters (IVC) in the treatment of venous thromboembolic disease (VTE). The PTE Working Group of SEPAR. Sociedad Española de Neumología y Cirurgía Torácica].一种非药物治疗策略：下腔静脉滤器（IVC）在静脉血栓栓塞性疾病（VTE）治疗中的应用。西班牙胸科与心血管外科学会肺血栓栓塞症工作组

Arch Bronconeumol. 1995 Aug-Sep;31(7):346-9.

9

[The results of the surveys of the Lung Cancer Task Force of the Spanish Society of Pneumology and Thoracic Surgery (SEPAR)].[西班牙肺科与胸外科协会（SEPAR）肺癌特别工作组的调查结果]

Arch Bronconeumol. 1994 Jan;30(1):40-8.

10

[Results of the surgical treatment of pathologic bronchogenic carcinoma N2 with negative mediastinoscopy].[纵隔镜检查阴性的病理性N2期支气管源性癌的外科治疗结果]

Arch Bronconeumol. 2000 Jul-Aug;36(7):365-70.

引用本文的文献

1

Impact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitors.慢性阻塞性肺疾病（COPD）对接受化疗和/或酪氨酸激酶抑制剂治疗的肺癌及晚期疾病患者的影响。

Int J Chron Obstruct Pulmon Dis. 2014 Sep 30;9:1053-8. doi: 10.2147/COPD.S68766. eCollection 2014.

2

Heterogeneity of prognostic profiles in non-small cell lung cancer: too many variables but a few relevant.非小细胞肺癌预后特征的异质性：变量众多但少数相关。

Eur J Epidemiol. 2005;20(11):907-14. doi: 10.1007/s10654-005-3634-7.